TY  - JOUR

T1  - Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase 3 trials of docetaxel and zoledronic acid using healthcare systems data

JO  - Annals of Oncology

UR  - https://doi.org/10.1016/j.annonc.2025.07.005

PY  - 2025/07/16

AU  - Jones C

AU  - Dutey-Magni P

AU  - Murphy LR

AU  - Murray ML

AU  - Brown JE

AU  - McCloskey E

AU  - Brown M

AU  - Amos CL

AU  - Gilbert DC

AU  - Jones RJ

AU  - Cross W et al

ED  - 

DO  - DOI: 10.1016/j.annonc.2025.07.005

PB  - Elsevier BV

Y2  - 2025/08/28

ER  -